Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

In the first 6 months of the immunosuppressive therapy, the MTT showed a trend for the benefit of immunosuppression with respect to transplant-free survival, but it missed statistical significance by one patient.

also in 53,322 other papers

The intermediate analysis of the immunosuppressive treatment arm showed a positive trend for EF and major adverse cardiac events after 6 months of treatment and significant benefit after 1 year of follow-up for both groups [ 26 ].

also in 11,005 other papers